Inhibrx Biosciences, Inc.

INBX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $1.9B · 110 employees
27
SEC Filings
$104.01
Close 2026-05-29
110
Employees

Business Summary

. Overview We are a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using our proprietary modular protein engineering platforms. We leverage our innovative protein engineering technologies and deep understanding of target biology to create therapeutic candidates with attributes and mechanisms we believe to be superior to current approaches and applicable to a range of challenging, validated targets with high potential. Recent Developme...

Latest Stock Quote

INBX 2026-05-29 $104.01 O:$104.12 H:$105.41 L:$101.37 Vol:0.2M VWAP:$103.3946
origin leaf: f173b4db2987801d1561f65a696789032691db6d295d6ba6299898d3c3e1c9e9

Next Earnings

Q2 FY2026 — expected 2026-08-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310002007919-26-000006EDGAR92K words
2025-03-172024-12-310002007919-25-000019EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300002007919-25-000093EDGAR23K words
2025-08-132025-06-300002007919-25-000081EDGAR—
2025-05-142025-03-310002007919-25-000056EDGAR—
2024-11-142024-09-300002007919-24-000058EDGAR—
2024-08-132024-06-300002007919-24-000029EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190002007919-26-000007EDGAR2K words
2026-02-230002007919-26-000002EDGAR—
2025-12-160002007919-25-000097EDGAR—
2025-11-140002007919-25-000094EDGAR—
2025-10-230002007919-25-000089EDGAR—
2025-08-130002007919-25-000083EDGAR—
2025-05-280002007919-25-000063EDGAR—
2025-05-140002007919-25-000057EDGAR—
2025-04-010002007919-25-000028EDGAR—
2025-03-170002007919-25-000020EDGAR—

27 total filings indexed. 10 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0002007919
TickerINBX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.inhibrx.com
Listed2024-05-28

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f3dbc361bd3f61e7ea70e7b40e1b791251a4d4c0f7e0ca2695e1d4efbabfec46
parent: ca8444aa2b9444c7cb4a273fd2c711d81b58949f8a72edaa1908930649d6348c
content hash: 10fe6121e78cc8a98fe5dd03cb9ae4f29c12617c205bbedb577b659f7878c5fb
signed: 2026-06-03T12:01:29.684Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf